Eagle Asset Management’s Aclaris Therapeutics ACRS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-1,380,549	Closed	-$36.4M	–	625
2017 Q3	$36.4M	Buy	1,380,549 +22,576	+2%	+$596K	0.21%	166
2017 Q2	$36.8M	Buy	1,357,973 +1,007,343	+287%	+$27.3M	0.22%	162
2017 Q1	$10.5M	Sell	350,630 -5,623	-2%	-$168K	0.07%	323
2016 Q4	$9.67M	Buy	+356,253	New	+$9.67M	0.06%	328